, Tracking Stock Market Picks
Enter Symbol:
Apricus Biosciences Inc (APRI) [hlAlert]

Strong Buy
down 62.95 %

Apricus Biosciences Inc (APRI) rated Strong Buy with price target $6 by Ascendiant Capital Markets

Posted on: Monday,  Jul 23, 2012  8:29 AM ET by Ascendiant Capital Markets

Ascendiant Capital Markets rated Strong Buy Apricus Biosciences Inc (NASDAQ: APRI) on 07/23/2012, when the stock price was $3.32.
Since then, Apricus Biosciences Inc has lost 62.95% as of 11/06/2015's recent price of $1.23.
If you would have followed this Ascendiant Capital Markets's recommendation on APRI, you would have lost 62.95% of your investment in 1201 days.

NexMed, Inc. is a pharmaceutical and medical technology company. They develop and commercialize therapeutic products based on proprietary delivery systems. They are currently focusing their efforts on new and patented pharmaceutical products based on a penetration enhancement topical delivery technology known as NexACT(R), which may enable an active drug to be better absorbed through the skin.

Ascendiant Capital Markets is led by George Santana, who has nearly twenty years of equity research experience in the United States and foreign markets. During his career, Mr. Santana has been recognized six consecutive times in the Institutional Investor magazine poll of top analysts.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
7/23/2012 8:29 AM Buy
3.32 6.00
as of 12/31/2012
1 Week down  -3.80 %
1 Month down  -8.18 %
3 Months down  -38.03 %
1 YTD down  -39.15 %

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy